Singapore markets closed

Dyadic International, Inc. (DYAI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6001+0.0101 (+0.64%)
As of 12:42PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.5900
Open1.5400
Bid1.1600 x 200
Ask1.9200 x 200
Day's range1.5000 - 1.6200
52-week range1.1900 - 2.4000
Volume9,393
Avg. volume23,983
Market cap46.361M
Beta (5Y monthly)0.59
PE ratio (TTM)N/A
EPS (TTM)-0.2400
Earnings date08 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript

    Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript March 28, 2024 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07. DYAI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good evening, and welcome […]

  • Thomson Reuters StreetEvents

    Q4 2023 Dyadic International Inc Earnings Call

    Q4 2023 Dyadic International Inc Earnings Call

  • GlobeNewswire

    Dyadic Reports 2023 Full Year Results and Recent Company Progress

    Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical safety and antibody response for DYAI-100 a recombinant protein receptor binding domain (RBD) booster vaccine candidate for protection against COVID-19 infection Entered into several fully funded vaccine and antibody projects covering more than twelve targets since announcing topline clinical safety d